Antibody persistence after pneumococcal conjugate vaccination in patients with chronic lymphocytic leukemia.

about

Antibody persistence after pneumococcal conjugate vaccination in patients with chronic lymphocytic leukemia.

Item

http://www.wikidata.org/entity/Q50116286

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Antibody persistence after pne ...... chronic lymphocytic leukemia.

@en

Antibody persistence after pne ...... chronic lymphocytic leukemia.

@nl

type

Item

label

Antibody persistence after pne ...... chronic lymphocytic leukemia.

@en

Antibody persistence after pne ...... chronic lymphocytic leukemia.

@nl

prefLabel

Antibody persistence after pne ...... chronic lymphocytic leukemia.

@en

Antibody persistence after pne ...... chronic lymphocytic leukemia.

@nl

P1476

Antibody persistence after pne ...... chronic lymphocytic leukemia.

@en

P2093

Heini Huhtala

http://www.w3.org/2001/XMLSchema#string

Helena Käyhty

http://www.w3.org/2001/XMLSchema#string

Janne Aittoniemi

http://www.w3.org/2001/XMLSchema#string

Maija Itälä-Remes

http://www.w3.org/2001/XMLSchema#string

Marjatta Sinisalo

http://www.w3.org/2001/XMLSchema#string

Urpu Salmenniemi

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic lymphocytic leukaemia: an overview of aetiology in light of recent developments in classification and pathogenesis

Perturbation of the normal immune system in patients with CLL

Disease-specific complications of chronic lymphocytic leukemia.

Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants.

Antibody and plasmablast response to 13-valent pneumococcal conjugate vaccine in chronic lymphocytic leukemia patients--preliminary report.

Multiple-dose granulocyte-macrophage-colony-stimulating factor plus 23-valent polysaccharide pneumococcal vaccine in patients with chronic lymphocytic leukemia: a prospective, randomized trial of safety and immunogenicity.

Effects of ageing and gender on naturally acquired antibodies to pneumococcal capsular polysaccharides and virulence-associated proteins

Antibody persistence and immunologic memory after sequential pneumococcal conjugate and polysaccharide vaccination in HIV-infected children on highly active antiretroviral therapy.

Infectious complications of chronic lymphocytic leukaemia: pathogenesis, spectrum of infection, preventive approaches.

Immunogenicity and safety of a second administration of 13-valent pneumococcal conjugate vaccine 5 years after initial vaccination in adults 50 years and older.

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21645515.2018.1436424

http://www.w3.org/2001/XMLSchema#string

P50

Vesa Lindström

P577

2018-02-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29420116

http://www.w3.org/2001/XMLSchema#string

P921

lymphocyte

P932

6037466

http://www.w3.org/2001/XMLSchema#string